Cancer News

Recent research has uncovered a crucial mechanism that may enhance our understanding of how cancer cells survive and how they might be compelled to undergo a unique form of cell death known as...

Recent advancements in cancer research have illuminated the complex mechanisms that dictate cancer cell survival and death. A new study from researchers at Zhejiang University and affiliated...

Recent research from the Icahn School of Medicine at Mount Sinai has shed light on a previously undiscovered pocket within the PKMYT1 protein, presenting a promising opportunity for the development...

Recent research from the Icahn School of Medicine at Mount Sinai has unveiled a hidden drug-binding pocket within the PKMYT1 protein, a critical player in cell growth and division. This discovery not...

In a significant advancement for pancreatic cancer treatment, researchers have unveiled a new drug that nearly doubles the survival rate for patients with previously treated metastatic pancreatic...

Recent advancements in pancreatic cancer treatment have emerged from a significant clinical trial that could reshape the landscape of care for one of the deadliest forms of cancer. At the American...

In a significant advancement for oncology, researchers at UCLA have been awarded a $3.2 million grant from the National Institutes of Health (NIH) to develop an innovative artificial intelligence...

Recent advancements in cancer treatment are taking a significant leap forward with the announcement from UCLA researchers who have secured a $3.2 million grant from the National Cancer Institute. Led...

In a significant advancement for cancer research and care, Dr. Mina Sedrak has been appointed as co-chair of the Cancer in the Older Adult Committee within The Alliance for Clinical Trials in...

Dr. Mina Sedrak, a prominent figure in oncology and aging research at UCLA, has been appointed as co-chair of the Cancer in the Older Adult Committee for The Alliance for Clinical Trials in Oncology....

Recent findings from a pilot study conducted by researchers at Vanderbilt Health and Cumberland Pharmaceuticals have shed light on a new potential treatment for high-risk solid tumors. The...

Recent research has unveiled promising advancements in the treatment of localized prostate cancer, particularly for patients classified as intermediate or high risk. A multicenter clinical trial led...

Recent findings from a significant clinical trial reveal that combining a new immunotherapy with standard radiation treatment can markedly improve disease-free survival rates for men with localized...

A recent study managed by the American College of Radiology (ACR) has revealed promising findings regarding the impact of GLP-1 medications on breast cancer risk. Involving a substantial cohort of...

Recent research presented at the 2026 ASCO Annual Meeting has highlighted an intriguing connection between GLP-1 medications and a reduced risk of breast cancer. The study, managed by the American...

Recent findings from the Mayo Clinic have unveiled a promising new combination of drugs that may significantly improve treatment outcomes for patients with advanced kidney cancer, particularly those...

Recent advancements in cancer treatment have led researchers at the Mayo Clinic to explore an innovative combination of drugs that shows early effectiveness in battling advanced kidney cancer. This...

In an era where artificial intelligence (AI) tools are increasingly utilized in healthcare, researchers at Binghamton University have made significant strides in ensuring the reliability of...

As artificial intelligence (AI) increasingly permeates everyday life, its application in healthcare diagnostics is becoming a focal point of research. A team at Binghamton University has made strides...

In a groundbreaking study presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, researchers revealed a promising link between GLP-1 medications and a reduced incidence of...